Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)

INTRODUCTION: Multiple sclerosis (MS) typically requires life-long management with disease-modifying therapies (DMTs). Many DMTs require regular self-injection, and can be associated with injection site reactions, pain, and needle/injection phobia—but these can be addressed by improvements in autoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemssen, Tjalf, Sylvester, Lauren, Rametta, Mark, Ross, Amy Perrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685867/
https://www.ncbi.nlm.nih.gov/pubmed/26662362
http://dx.doi.org/10.1007/s40120-015-0036-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685867/
https://www.ncbi.nlm.nih.gov/pubmed/26662362
http://dx.doi.org/10.1007/s40120-015-0036-y

Ejemplares similares